CanSino Biologics (CanSino Biologics) 3-Year Revenue Growth Rate : 152.50% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CanSino Biologics 3-Year Revenue Growth Rate?

CanSino Biologics's Revenue per Share for the three months ended in Mar. 2024 was $0.06.

During the past 12 months, CanSino Biologics's average Revenue per Share Growth Rate was -30.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 152.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 8 years, the highest 3-Year average Revenue per Share Growth Rate of CanSino Biologics was 1424.90% per year. The lowest was 152.50% per year. And the median was 788.70% per year.

Competitive Comparison of CanSino Biologics's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, CanSino Biologics's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CanSino Biologics's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanSino Biologics's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where CanSino Biologics's 3-Year Revenue Growth Rate falls into.

CanSino Biologics 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

CanSino Biologics (OTCPK:CASBF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

CanSino Biologics 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

CanSino Biologics (CanSino Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (OTCPK:CASBF) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

06185:Hong Kong CJH:Germany 688185:China

Address

185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN

Website

https://www.cansinotech.com

CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing and commercialization of vaccine products for human use. These include products such as pneumococcal polysaccharide and conjugate vaccines as well as a DTcP-based combo and other items. At the same time, the group is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine. Geographically, the activities are carried out through China.